CoChat

Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy

Open access
Weber, Franziska D., Weinhofer, Isabelle, Einwich, Angelika, Forss-Petter, Sonja, Muneer, Zahid, Maier, Harald, Weber, Willi H. A., Berger, Johannes · 2014 · PLoS ONE

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is a clinically heterogeneous disease that can manifest as devastating inflammatory cerebral demyelination (CALD) leading to death of affected males. Currently, the only curative treatment is allogeneic hematopoietic stem cell transplantation (HSCT). However, HSCT is only effective when performed at an early stage because the inflammation may progress for eighteen months after HSCT. Thus, alternative treatment options able to immediately halt the progression are urgently needed. X-ALD is caused by mutations in the ABCD1 gene, encoding the peroxisomal membrane protein ABCD1, resulting in impaired very long-chain fatty acid metabolism. The related ABCD2 protein is able to functionally compensate for ABCD1-deficiency both in vitro and in vivo. Recently, we demonstrated that of the cell types derived from CD34+ stem cells, predominantly monocytes but not lymphocytes are metabolically impaired in X-ALD. As ABCD2 is virtually not expressed in these cells, we hypothesize that a pharmacological up-regulation of ABCD2 should compensate metabolically and halt the inflammation in CALD. Retinoids are anti-inflammatory compounds known to act on ABCD2. Here, we investigated the capacity of selected retinoids for ABCD2 induction in human monocytes/macrophages. In THP-1 cells, 13-cis-retinoic acid reached the highest, fivefold, increase in ABCD2 expression. To test the efficacy of retinoids in vivo, we analyzed ABCD2 mRNA levels in blood cells isolated from acne patients receiving 13-cis-retinoic acid therapy. In treated acne patients, ABCD2 mRNA levels were comparable to pre-treatment levels in monocytes and lymphocytes. Nevertheless, when primary monocytes were in vitro differentiated into macrophages and treated with 13-cis-retinoic acid, we observed a fourfold induction of ABCD2. However, the level of ABCD2 induction obtained by retinoids alone is probably not of therapeutic relevance for X-ALD. In conclusion, our results suggest a change in promoter accessibility during macrophage differentiation allowing induction of ABCD2 by retinoids.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0103742

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A complex regulatory network operates at the human ABCD2 promoter. Activation and inhibition of the ABCD2 gene are indicated. Nucleotide positions relative to the translational start site are indicated below the sequence. SREBP = sterol regulatory element (SRE)-binding proteins; LXR = liver X receptor; TR = thyroid hormone receptor; RXR = retinoid X receptor; RAR = retinoic acid receptor; TCF-4 = T-cell factor 4; Sp-1/3 = specificity protein 1/3; DR = direct repeat spaced by 1/2/4 or 5 nucleotides; TBE 1/3 = TCF binding element; 22R-HC = 22(R)-hydroxycholesterol; 9/13CRA = 9/13-cis-retinoic acid; T3 = triiodothyronine; 4-PBA = 4-phenylbutyrate; SAHA = suberoylanilide hydroxamic acid.
Figure 1 A complex regulatory network operates at the human ABCD2 promoter. Activation and inhibition of the ABCD2 gene are indicated. Nucleotide positions relative to the translational start site are indicated below the sequence. SREBP = sterol regulatory element (SRE)-binding proteins; LXR = liver X receptor; TR = thyroid hormone receptor; RXR = retinoid X receptor; RAR = retinoic acid receptor; TCF-4 = T-cell factor 4; Sp-1/3 = specificity protein 1/3; DR = direct repeat spaced by 1/2/4 or 5 nucleotides; TBE 1/3 = TCF binding element; 22R-HC = 22(R)-hydroxycholesterol; 9/13CRA = 9/13-cis-retinoic acid; T3 = triiodothyronine; 4-PBA = 4-phenylbutyrate; SAHA = suberoylanilide hydroxamic acid.CC BY · PubMed Central
Figure 2 Agonists of RAR and RXR induce ABCD2 mRNA expression in THP-1 cells. The mRNA levels of ABCD2 and the reference gene HPRT were determined by qRT-PCR after 24-h-treatment with the indicated concentrations of (A) 9CRA, (B) 13CRA, (C) ATRA and (D) Adapalene. The receptor-selectivity of each ligand is indicated below the panels. (E) Dose-response curve for 13CRA. Values represent means ± SEM of treated cells as fold-induction relative to solvent (DMSO)-treated cells. Each column represents three independent treatments. qRT-PCR analyses were performed in 2–3 technical replicates. ** p<0.01; *** p<0.001; ns, not significant.
Figure 2 Agonists of RAR and RXR induce ABCD2 mRNA expression in THP-1 cells. The mRNA levels of ABCD2 and the reference gene HPRT were determined by qRT-PCR after 24-h-treatment with the indicated concentrations of (A) 9CRA, (B) 13CRA, (C) ATRA and (D) Adapalene. The receptor-selectivity of each ligand is indicated below the panels. (E) Dose-response curve for 13CRA. Values represent means ± SEM of treated cells as fold-induction relative to solvent (DMSO)-treated cells. Each column represents three independent treatments. qRT-PCR analyses were performed in 2–3 technical replicates. ** p<0.01; *** p<0.001; ns, not significant.CC BY · PubMed Central
Figure 3 ABCD2 mRNA is not induced in monocytes or lymphocytes of acne patients treated with 13CRA. ABCD1, ABCD2, ABCD3 and HPRT mRNA levels were measured by qRT-PCR in (A) monocytes (CD14+) and (B) B cells (CD19+) of healthy controls and acne patients before and after oral treatment with 13CRA for a period of about 3 months. HPRT was used for normalization of the absolute mRNA copy numbers. Values represent means ± SEM; qRT-PCR analyses were performed in technical duplicates. The number of individuals (n) is indicated in the inserts.
Figure 3 ABCD2 mRNA is not induced in monocytes or lymphocytes of acne patients treated with 13CRA. ABCD1, ABCD2, ABCD3 and HPRT mRNA levels were measured by qRT-PCR in (A) monocytes (CD14+) and (B) B cells (CD19+) of healthy controls and acne patients before and after oral treatment with 13CRA for a period of about 3 months. HPRT was used for normalization of the absolute mRNA copy numbers. Values represent means ± SEM; qRT-PCR analyses were performed in technical duplicates. The number of individuals (n) is indicated in the inserts.CC BY · PubMed Central
Figure 4 13CRA mediates a modest induction of ABCD2 in differentiated human macrophages in vitro. (A) ABCD1, ABCD2, ABCD3, and, as a reference for normalization, HPRT mRNA levels were detected by qRT-PCR after treatment of in vitro differentiated macrophages with 2.5, 5 and 7 µM of 13CRA for 24 h. The results are shown as fold-induction of ABCD1-3/HPRT relative to solvent (DMSO)-treated cells. (B) As a control for the differentiation of monocytes into macrophages, LXRα expression was quantified and depicted as copy numbers of LXRα mRNA normalized to HPRT mRNA levels. (C) ABCD2 mRNA levels were similar in monocytes and M-CSF-differentiated macrophages. Values represent means ± SEM of three independent treatments. qRT-PCR analyses were performed in two technical replicates. * p<0.05; ** p<0.01; *** p<0.001; ns, not significant.
Figure 4 13CRA mediates a modest induction of ABCD2 in differentiated human macrophages in vitro. (A) ABCD1, ABCD2, ABCD3, and, as a reference for normalization, HPRT mRNA levels were detected by qRT-PCR after treatment of in vitro differentiated macrophages with 2.5, 5 and 7 µM of 13CRA for 24 h. The results are shown as fold-induction of ABCD1-3/HPRT relative to solvent (DMSO)-treated cells. (B) As a control for the differentiation of monocytes into macrophages, LXRα expression was quantified and depicted as copy numbers of LXRα mRNA normalized to HPRT mRNA levels. (C) ABCD2 mRNA levels were similar in monocytes and M-CSF-differentiated macrophages. Values represent means ± SEM of three independent treatments. qRT-PCR analyses were performed in two technical replicates. * p<0.05; ** p<0.01; *** p<0.001; ns, not significant.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 8

Metadata

Authors
Weber, F. D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W. H. A., & Berger, J.
Affiliations
Medical University of Vienna (AT)
Corresponding author
Berger, Johannes
Venue
PLoS ONE
Published
2014-07-31
Volume
9
Issue
7
Pages
e103742
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2098906082
Cited by
8
References
43
Citations by year
2026: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2015: 3 · 2014: 1
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • European Commission (241622)
  • Austrian Science Fund (T562, P26112, P26112-B19,)
  • Higher Education Commision, Pakistan
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
X-linked adrenoleukodystrophy, ABCD2, retinoids, isotretinoin, ABCD1, peroxisomal disorders, monocytes, macrophages, THP-1 cells, acne, promoter accessibility, brain demyelination, gene compensation
MeSH terms
ATP Binding Cassette Transporter, Subfamily D, Acne Vulgaris, Adolescent, Adrenoleukodystrophy, Adult, Cell Line, Humans, Macrophages, Male, Retinoids, Transcriptional Activation, Gene Expression, Case-Control Studies, ATP-Binding Cassette Transporters, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy. https://app.cochat.ai/papers/10.1371/journal.pone.0103742
The paper
Weber, F. D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W. H. A., & Berger, J. (2014). Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy. PLoS ONE. https://doi.org/10.1371/journal.pone.0103742

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.